Alexandria Ashour represents private and publicly held companies in a range of corporate and securities matters, including private financings, initial public offerings, mergers and acquisitions and corporate governance.
Cooley represented Shoreline Biosciences, a biotechnology company developing cellular immunotherapies, on its $140 million financing led by Ally Bridge Group. Partner Tom Coll led the Cooley team.
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
December 9, 2021
Cooley advised Alvotech Holdings, a global biopharmaceutical company focused on the development and manufacturing of biosimilar medicines for patients worldwide, on its agreement to merge with special purpose acquisition company (SPAC) Oaktree Acquisition Corp. II. Lawyers Michal Berkner, Div Gupta, Nicolas Dumont and Jarrett Burks led the Cooley team advising Alvotech.
